Alterity Therapeutics Limited (ASX:ATH)
0.0080
+0.0010 (14.29%)
Mar 9, 2026, 1:20 PM AEST
Alterity Therapeutics Employees
Alterity Therapeutics had 9 employees as of June 30, 2025. The number of employees decreased by 1 or -10.00% compared to the previous year.
Employees
9
Change (1Y)
-1
Growth (1Y)
-10.00%
Revenue / Employee
737.38K AUD
Profits / Employee
-1.62M AUD
Market Cap
76.13M
Employees Chart
Alterity Therapeutics News
- 4 days ago - Alterity Therapeutics Announces Appointment Of Daniel Claassen As Chief Medical Advisor - Nasdaq
- 6 days ago - Alterity Therapeutics Recognizes Multiple System Atrophy (MSA) Awareness Month in March and the Urgent Need for Disease-Modifying Treatments - GlobeNewsWire
- 5 weeks ago - Alterity Therapeutics (ATHE) Advances Phase 3 Program with Strong Financials - GuruFocus
- 5 weeks ago - Alterity Therapeutics: Appendix 4C – Q2 FY26 Quarterly Cash Flow Report & Corporate Update - GlobeNewsWire
- 6 weeks ago - Alterity Therapeutics (ATHE) Advances towards Phase 3 Trials with Promising MSA Treatment - GuruFocus
- 3 months ago - Alterity Therapeutics (ATHE) Pioneers Unique Approach to Neurodegeneration - GuruFocus
- 3 months ago - Alterity Therapeutics (ATHE) Focuses on Parkinson's Disease Research - GuruFocus
- 4 months ago - Alterity Therapeutics to Present at the Bell Potter Healthcare Virtual Conference - GlobeNewsWire